Skip to main content

Table 4 Summary of clinicopathological parameters of the study cohort

From: Identification of novel long non-coding RNAs in clear cell renal cell carcinoma

  Screening cohort Validation cohort
  n= 15 (%) Cancer n= 55 (%) Normal n= 52 (%)
Sex    
  Male 10 (66.6) 37 (67.3) 36 (69.2)
  Female 5 (33.3) 18 (33.7) 16 (30.8)
Age    
  Mean 61.2 62.9 62.1
  Min-max 43–86 36–86 36–86
Pathological stage    
  pT1 4 (26.7) 29 (52.7) n.a.
  pT2 2 (13.3) 7 (12.7) n.a.
  pT3 9 (60.0) 18 (32.7) n.a.
  pT4 0 (0) 1 (1.8) n.a.
  Vascular invasion 7 (46.7) 16 (29.1) n.a.
  Lymph node metastasis 0 (0) 2 (3.6) n.a.
  Distant metastasis 1 (6.7) 7 (12.7) n.a.
AJCC staging group    
  I 4 (26.7) 26 (47.3) n.a.
  II 1 (6.7) 5 (9.1) n.a.
  III 9 (60.0) 16 (29.1) n.a.
  IV 1 (6.7) 8 (14.5) n.a.
Fuhrman grading    
  Grade 1 2 (13.3) 4 (7.3) n.a.
  Grade 2 11 (73.3) 41 (74.5) n.a.
  Grade 3 2 (13.3) 9 16.3) n.a.
  Grade 4 0 (0) 1 (1.8) n.a.
  1. n.a. not applicable.